Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
⚠️ Adverse reactions: Sulphonamides carry a risk of Stevens–Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, and aplastic anaemia. Monitor closely for rash, cytopenia, or hepatic dysfunction, particularly in long-term use.
| Indication | Dose | Frequency | Route |
|---|---|---|---|
| Glaucoma | 250–500 mg/day | Divided doses | PO |
| Altitude sickness | 125–250 mg | BD | PO (start 24–48h before ascent) |
| Epilepsy | 250 mg–1 g/day | Divided doses | PO |
| Idiopathic intracranial hypertension | 250 mg–1 g/day | Divided doses | PO |
Acetazolamide illustrates how renal physiology links to multiple systems: by reducing bicarbonate reabsorption, it alters CSF and aqueous humour dynamics as well as systemic acid–base balance. Its effect on ventilation in altitude sickness is due to a mild metabolic acidosis driving compensatory hyperventilation — a neat physiological feedback mechanism to improve oxygenation at altitude.